CAS RN: 5545-52-8
N-Cbz-L-Aspartic acid 4-tert-butyl ester
Product Availability
Choose a grade to view its available package options.
1 package records1 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20250806 |
5g / 25g / 100g |
Confirm by inquiry |
Shanghai, Shandong | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 5g, 10g, 25g, 100g, 500g, 1000g
- Available purity: ≥97%
- Inventory rows with stock: 1
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 5545-52-8
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 5g |
≥97% |
5
In Stock
|
Beijing |
Inquiry |
| 10g |
≥97% |
0
Out of Stock
|
Shanghai |
Inquiry |
| 25g |
≥97% |
0
Out of Stock
|
Shanghai |
Inquiry |
| 100g |
≥97% |
0
Out of Stock
|
Shenzhen |
Inquiry |
| 500g |
≥97% |
0
Out of Stock
|
Shanghai |
Inquiry |
| 1000g |
≥97% |
0
Out of Stock
|
Hong Kong |
Inquiry |
5545-52-8 / (2S)-4-[(2-methylpropan-2-yl)oxy]-4-oxo-2-(phenylmethoxycarbonylamino)butanoic acid
Standard CAS: 5545-52-8
Multi CAS: Yes
Basic Information
CAS
5545-52-8
Multi CAS
Yes
Molecular Formula
C16H21NO6
Molecular Weight
323.340000
Exact Mass
323.136887
InChI
InChI=1S/C16H21NO6/c1-16(2,3)23-13(18)9-12(14(19)20)17-15(21)22-10-11-7-5-4-6-8-11/h4-8,12H,9-10H2,1-3H3,(H,17,21)(H,19,20)/t12-/m0/s1
InChIKey
HLSLRFBLVZUVIE-LBPRGKRZSA-N
Computed Properties
Structural Parameters
Heavy atom count
23
Aromatic heavy atom count
6
Fraction Csp3
0.44
Rotatable bonds
6
H-bond acceptors
5
H-bond donors
2
Molar refractivity
81.65
TPSA
101.93
LogP / Solubility
WLOGP
2.1
MLOGP
1.86
XLogP3
1.9
Consensus LogP
1.95
Log S (ESOL)
-2.96
Class (ESOL)
Moderately soluble
Log S (Ali)
-3.73
Class (Ali)
Poorly soluble
Log S (SILICOS-IT)
-4.22
Class (SILICOS-IT)
Slightly soluble
ADME
GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.2
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
Yes
Synthetic Accessibility
3